title: Esophageal adenocarcinoma after laparoscopic gastric band placement for obesity.
abstract: Obesity is a risk factor for the development of esophageal malignancy. We report a case of the development of esophageal adenocarcinoma after placement of an adjustable gastric band for obesity. A 66-year-old male was referred to our clinic for findings of an obstructing mass at the gastroesophageal junction after previously undergoing a laparoscopic adjustable gastric band placement. Investigations confirmed a locally advanced poorly differentiated esophageal adenocarcinoma. The patient underwent chemotherapy and gastric band removal with improvement of his dysphagia. However, his disease progressed and he died of metastatic disease. We discuss the diagnosis of esophageal carcinoma after gastric banding procedure.
authors.affiliation: Department of General Surgery, Mayo Clinic, Jacksonville, Florida, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Stauffer
authors.forename: J
authors.initials: J
authors.lastname: Mathew
authors.forename: J A
authors.initials: JA
authors.lastname: Odell
mesh_terms: D000230:Adenocarcinoma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D050110:Bariatric Surgery; D003680:Deglutition Disorders / Q000209:etiology; D018450:Disease Progression; D015251:Epirubicin / Q000008:administration & dosage; D004938:Esophageal Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D017809:Fatal Outcome; D005472:Fluorouracil / Q000008:administration & dosage; D005764:Gastroesophageal Reflux; D006801:Humans; D008297:Male; D009765:Obesity / Q000150:complications* / Q000601:surgery; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D015251:Epirubicin; D005472:Fluorouracil